[Preliminary results of treatment with Tagamet (cimetidine SK and F) in gastric and duodenal ulcers]

Minerva Med. 1978 Jul 14;69(34):2297-306.
[Article in Italian]

Abstract

Following 3x200 mg Tagament (cymetidine SK & F) tablets at meals and 2 in the evening (5 per day) for an average of 31 days, complete endoscopic cure was obtained after 29 days (duodenal patients) and 35 days (gastric patients) in 26/27 subjects with slow healing histories (17 with duodenal and 10 with gastric ulcer). Rapid regression of pain and dyspepsia was observed form the outset and there was a marked reduction in the consumption of antacid preparation. Its marked efficacy and good tolerance make Tagamet a drug of choice in the treatment of peptic, duodenal and gastric ulcers.

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Adult
  • Cimetidine / administration & dosage
  • Cimetidine / therapeutic use*
  • Clinical Trials as Topic
  • Drug Evaluation
  • Drug Tolerance
  • Female
  • Guanidines / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Peptic Ulcer / drug therapy*

Substances

  • Guanidines
  • Cimetidine